Dr Elisa Sicuri is an economist working on health economics in low- and middle-income countries with a focus on infectious diseases, particularly neglected tropical diseases and vector-borne diseases.
In addition to being a Visiting Senior Fellow at LSE Health, she is a tenured Associate Research Professor at the Barcelona Institute for Global Health (ISGlobal) and Associate Professor at the University of Barcelona. She is also an Associated Researcher at the Manhiça Health Research Centre (CISM) in Mozambique. She is the PI of the Global Health Economics Group at ISGlobal.
Currently, Elisa is leading the health economics workstreams of the following competitive projects:
- EBO-PEP (Ebola Zaire Post-Exposure Prophylaxis), funded by EDCTP.
- African Leishmaniasis Consortium (ALC), funded by the Science for Africa Foundation link.
- REVERSE (Prevention and Management Tools for Reducing Antibiotic Resistance in High Prevalence Settings), funded by EC H2020 link.
- ANTICOV ANRS COV33 Coverage-Africa: A multi-arm study for early treatment of vulnerable populations with non-severe SARS-CoV-2, funded by Inserm-ANRS.
- ORCHESTRA (Connecting European Cohorts to Increase Common and Effective Response to the SARS-CoV-2 Pandemic), funded by EU H2020 link.
- INCENTIVE (Indo-European Consortium for Next-Generation Influenza Vaccine Innovation), funded by EC H2020 link.
- Cruzivax (Vaccine for the Prevention and Treatment of Trypanosoma Cruzi Infection), funded by EC H2020 link.